Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

18.2%

4 terminated out of 22 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

75%

6 of 8 completed with results

Key Signals

6 with results67% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (12)
P 1 (3)
P 2 (5)
P 3 (1)

Trial Status

Completed8
Recruiting5
Terminated4
Unknown3
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT05446584Phase 2Recruiting

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

NCT04240561Not ApplicableRecruiting

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

NCT06041152Phase 2Active Not RecruitingPrimary

Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment

NCT05987007Not ApplicableNot Yet Recruiting

Sleep Interventions and Neurocognitive Outcomes

NCT04504630Not ApplicableCompletedPrimary

Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury

NCT05903573Not ApplicableRecruitingPrimary

Training Response Artificial Intelligence Network (TRAIN)

NCT04185298Not ApplicableTerminatedPrimary

mSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Amnestic Mild Cognitive Impairment

NCT06444568Not ApplicableRecruiting

Modified Ketogenic Diet in Amnestic Mild Cognitive Impairments

NCT01767909Phase 2CompletedPrimary

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

NCT06050603Not ApplicableRecruiting

MRI Guided Closed-loop TMS-EEG

NCT04063956Not ApplicableUnknownPrimary

COG-REAGENT: COGnitive tRaining in patiEnts With Amnestic Mild coGnitive impairmENT

NCT04103463Not ApplicableUnknownPrimary

Interactive Stepping Exercise on Memory

NCT01953601Phase 3TerminatedPrimary

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

NCT03133052Not ApplicableUnknownPrimary

CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI)

NCT00643266Not ApplicableCompletedPrimary

Recollection Training in Healthy Older Adults and Older Adults With Amnestic Mild Cognitive Impairment

NCT02910739Phase 1CompletedPrimary

An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

NCT02562989Phase 1Completed

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

NCT01962038Not ApplicableCompletedPrimary

A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment

NCT00582855Phase 2Terminated

Effect of AQW051 in Patients With Memory Impairment

NCT01072812Phase 1Terminated

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

Scroll to load more

Research Network

Activity Timeline